Spectrum Pharmaceuticals Hit With Shareholder Class Action
Spectrum Pharmaceuticals Inc. was hit with a putative class action in Nevada federal court Thursday, accusing the biotechnology company of misleading investors about the sales potential of cancer treatment Fusilev, causing...To view the full article, register now.
Already a subscriber? Click here to view full article